Bridge to Transplant is complete - Outcome due Q4Destination Therapy - Trial Completion possibly end of Q4 - Approval end 2012
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025